BR

Bodu Ram Yadav

Active Director Director DIN 11276567
DIN 11276567 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Bodu Ram Yadav

Data last updated:

Bodu Ram Yadav is a Director at Economex Pharma Private Limited (since 2025). The company operates in Pharma. Economex Pharma Private Limited reported revenue of ₹15.1 Lakh (FY 2024).

DIN 11276567
Primary Designation Director
Industry Pharma
First Appointment 08 Sep 2025
Largest company Economex Pharma Private Limited · ₹15.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Economex Pharma Private Limited U24230RJ2021PTC074644
Director08 Sep 2025₹15.1 Lakh (FY 2024)Active

Board colleagues of Bodu Ram Yadav

NameDINCompanyDesignation
Mukesh Kumar Yadav09151591Economex Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Economex Pharma Private Limited
Premium access

Shareholding and investment profile for Bodu Ram Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bodu Ram Yadav

Bodu Ram Yadav currently holds 1 directorship: Economex Pharma Private Limited (Director, since 08 Sep 2025, revenue ₹15.1 Lakh (FY 2024)).

Bodu Ram Yadav was first appointed on 08 Sep 2025 as Director at Economex Pharma Private Limited.

The current boards of Bodu Ram Yadav's companies include Mukesh Kumar Yadav (Economex Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available